Skip to main content

Table 2 IHC characterisations in BCS Patients

From: Detection of BCOR gene rearrangement in Ewing-like sarcoma: an important diagnostic tool

Case

CD99

Fli-1

CCNB3

BCOR

DUX4

Nkx2.2

WT-1

calretinin

MUC4

TLE1

EMA

1

Negative

Negative

Positive

Positive

Negative

Negative

Negative

Negative

Negative

Positive

Negative

2

Negative

Negative

Negative

Positive

Negative

Negative

Negative

Negative

Negative

Positive

Negative

3

Negative

Negative

Positive

NA

Negative

Negative

Negative

Negative

Negative

Positive

Negative

4

Positive

Negative

Positive

Positive

Negative

Negative

Negative

Negative

Negative

Positive

Negative

5a

Negative

NA

Positive

Negative

Negative

Negative

Negative

NA

NA

Positive

NA

6

Negative

NA

Positive

Negative

Negative

Negative

Negative

NA

NA

Positive

NA

7

Negative

NA

Positive

Positive

Negative

Negative

NA

NA

Negative

Positive

Negative

8*

Negative

Negative

Positive

Positive

Negative

Negative

Negative

NA

Negative

Positive

Negative

  1. aIHC was performed on the specimen after neoadjuvant chemotherapy; NA not available